UMass Chan Medical School at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
UMass Chan Medical School brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on viral gene delivery in large animals. Topics include modified adenoviral vectors for airway progenitor cells in ferrets and the efficiency and toxicity of high systemic AAV doses in advanced Duchenne muscular dystrophy.
| Organization | ESGCT 2026 Attendance |
|---|---|
UMass Chan Medical School Worcester, MA | |
Medical school in Worcester, Massachusetts, home to the Horae Gene Therapy Center, which develops AAV gene therapies for rare diseases. | Poster Thu Oct 29 2:00pm–4:00pm Evaluation of Modified rAd5 Vectors for Efficient and Low-Immunogenic Gene Delivery to Ferret Airway Progenitor Cells In Vivo Talk Fri Oct 30 10:15am–10:30am Gene delivery efficiency and toxicity of high systemic dose AAV in a large animal model of Duchenne muscular dystrophy with advanced disease Vectors and delivery (AAV, lentiviral, LNP)Rare and inherited disease |
Instantly find 20 buyers from UMass Chan Medical School
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction